Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC): Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263769).
- Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00113230).
- Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors: primary endpoint…
- Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03747120).
- Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00243191).
- Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03237377).
- Neoadjuvant Immunotherapy in Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Immunotherapy in Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04434560).
- Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04869137).
- Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Pazopanib in Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Pazopanib in Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01361113).
- Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2: primary endpoint results, effect estimate…
- Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00887575).
- Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00828308).
- Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03096418).
- NeoALTTOIndependent statistical analysis of the phase 3 NeoALTTO trial of lapatinib and trastuzumab in neoplasms of the breast, including pathological complete response, event-free survival, overall survival, landmark analyses, methodology, and interpretation.
- NEOARTIndependent statistical analysis of A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring…
- NeoChord TACT Post-Market Surveillance Registry: Complete Statistical AnalysisIndependent statistical analysis of NeoChord TACT Post-Market Surveillance Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01784055).
- Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN: Complete Statistical AnalysisIndependent statistical analysis of Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NeoFINDIndependent statistical analysis of [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NeohttpIndependent statistical analysis of Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02345772).
- NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test: Complete Statistical AnalysisIndependent statistical analysis of NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03522675).
- NEOMUNIndependent statistical analysis of Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03197467).
- Neonatal Intensive Care Unit Virtual Family-Centered Rounds: Complete Statistical AnalysisIndependent statistical analysis of Neonatal Intensive Care Unit Virtual Family-Centered Rounds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05762835).
- Neonatal Outcome by Reason for Delivery: Complete Statistical AnalysisIndependent statistical analysis of Neonatal Outcome by Reason for Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01818518).
- Neonatal Warming to Prevent Hypothermia: Complete Statistical AnalysisIndependent statistical analysis of Neonatal Warming to Prevent Hypothermia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04827394).
- NeoPHOEBEIndependent statistical analysis of NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NeoResIndependent statistical analysis of Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NeoSTOPIndependent statistical analysis of Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NeoSTOP-ITIndependent statistical analysis of Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NEOSURFIndependent statistical analysis of Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NEOTHROCOVIDIndependent statistical analysis of Thromboembolic Risk Screening in Patients With Cancer and COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04616846).
- NEPALIndependent statistical analysis of A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- NEPTUNEIndependent statistical analysis of Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE): primary endpoint results, effect estimate with confidence interval, sample-size…
- Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer: primary endpoint results, effect estimate with…
- Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain: Complete Statistical AnalysisIndependent statistical analysis of Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nesiritide Use Following Cardiac Surgery in Infants: Complete Statistical AnalysisIndependent statistical analysis of Nesiritide Use Following Cardiac Surgery in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00281671).
- NESTIndependent statistical analysis of Nitrous Oxide for Pain Management During In-office Transcervical Sterilization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312739).
- NEST-1Independent statistical analysis of Combination Immunotherapy in Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05571293).
- NeSTSIndependent statistical analysis of Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05269953).
- NETTER-1Independent statistical analysis of the phase 3 NETTER-1 trial comparing 177Lu-DOTA0-Tyr3-Octreotate with Octreotide LAR in patients with inoperable, progressive, somatostatin receptor positive midgut carcinoid tumours.
- Network Support for Alcohol Treatment 2: Complete Statistical AnalysisIndependent statistical analysis of Network Support for Alcohol Treatment 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01129804).